Conquest Research, LLC - Virginia - Vienna

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Alzheimer disease
• Schizophrenia

Running trials

• Recruiting

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source

  Contact: Henry Tran, Site 1241

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting
• Schizophrenia1 recruiting